Abstract:Context: Choline is a critical nutrient. Inadequate choline intake during pregnancy increases the risk of adverse maternal and offspring health. Objective: A systematic review and meta-analysis were conducted to examine the current recommendations for choline intake by pregnant women, estimate the overall prevalence of pregnant women with adequate choline intake, and explore associations between maternal choline level and adverse pregnancy outcomes (APOs). Methods: Choline recommendations for pregnant women were assessed from eight nutrient guidelines of the United States, United Kingdom, Canada, Australia, Asia, International Federation of Gynecology and Obstetrics, and World Health Organization. Data on the prevalence of pregnant women with adequate choline intake and the association between maternal choline level and APOs were collected from 5 databases up to May 2023. Meta-analyses with random effects and subgroup analyses were performed for the pooled estimate of prevalence and association. Results: Five recent nutrition guidelines from the United States (United States Department of Agriculture), United States (Food and Drug Administration), Canada, Australia, and the International Federation of Gynecology and Obstetrics have emphasized the importance of adequate choline intake for pregnant women. Of 27 publications, 19 articles explored the prevalence and 8 articles explored the association. Meta-analysis of 12 prevalence studies revealed a concerning 11.24% (95% confidence interval, 6.34-17.26) prevalence of pregnant women with adequate choline intake recommendations. A meta-analysis of 6 studies indicated a significant association between high maternal choline levels and a reduced risk of developing APOs, with an odds ratio of 0.51 (95% confidence interval, 0.40-0.65). Conclusion: The existing guidelines highlight the importance of choline in supporting maternal health and fetal development during pregnancy. Furthermore, a high maternal choline level was likely to be associated with a lower risk of APOs. However, 88.76% of pregnant women do not achieve the optimal choline intake. Therefore, specific policies and actions may be necessary to improve choline intake in pregnant women's care and support the well-being of pregnant women. Systematic review registration: PROSPERO registration no. CDR42023410561.

Pregnancy Status and Choline Intake Alter DNA Integrity, Epigenetic Marks and Gene Expression

Pregnancy Induces Transcriptional Activation of the Peripheral Innate Immune System and Increases Oxidative DNA Damage among Healthy Third Trimester Pregnant Women.

Pregnancy and Choline Intake Alter the Metabolic Use of Orally Consumed Choline in Women Consuming Deuterium Labeled Choline

A Higher Maternal Choline Intake Favorably Alters Placental Gene Expression of Biological Pathways Related to Disease Risk

Maternal Choline Intake Modulates Maternal and Fetal Biomarkers of Choline Metabolism in Humans

Pregnancy Alters Choline Dynamics: Results of a Randomized Trial Using Stable Isotope Methodology in Pregnant and Nonpregnant Women.

Fetal Stress Markers Are Lowered by Maternal Choline Intakes Exceeding Recommendations

Maternal Choline Intake Alters the Epigenetic State of Fetal Cortisol‐regulating Genes in Humans

Maternal Choline Supplementation Alters Vitamin B-12 Status in Human and Murine Pregnancy

Choline Affects Placental Vascular Function and Development in a Dose Response Manner

Choline Intake Influences Phosphatidylcholine DHA Enrichment in Nonpregnant Women but Not in Pregnant Women in the Third Trimester.

Maternal Choline Supplementation During Normal Murine Pregnancy Alters the Placental Epigenome: Results of an Exploratory Study.

A Genome‐Wide Analysis of Placental Epigenetic Markers in Response to Maternal Choline Supplementation

Pregnancy Increases the Use of Choline Derived Methyl Groups for Phosphatidylcholine (PC) Production Through the PEMT Pathway with Subsequent Selective Transfer of PEMT‐PC to the Fetus

A Higher Maternal Choline Intake among Third‐trimester Pregnant Women Lowers Placental and Circulating Concentrations of the Antiangiogenic Factor Fms‐like Tyrosine Kinase‐1 (Sflt1)

Choline: Exploring the Growing Science on Its Benefits for Moms and Babies.

Choline in pregnant women: a systematic review and meta-analysis

Influence of Lactation and Choline Intake on One‐carbon Biomarkers in Women

Maternal Choline Supplementation Modulates Maternal and Fetal Choline Metabolism and Downregulates Inflammatory Gene Expression in a Mouse Model of Placental Insufficiency

Epigenetic Genome Modifications during Pregnancy: The Impact of Essential Nutritional Supplements on DNA Methylation

Maternal Choline Supplementation Modulates Placental Nutrient Transport and Metabolism in Late Gestation of Mouse Pregnancy.